Clinical Trials Browser

Phase 2 × ammonium trichloro(dioxoethylene-O,O'-)tellurate × Clear all

NCT01010373 2015-02-10

Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients

Phase 2 Suspended

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00926354 2011-06-21

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

Phase 2 Terminated

Classical hematology

Chemotherapy Induced Thrombocytopenia